Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Plos One|September 16, 2014
Patients with exon 19 deletion were associated with longer progression-free survival compared to those with L858R mutation after first-line EGFR-TKIs for advanced non-small cell lung cancer: a meta-analysisYaxiong Zhang, Jin Sheng, Shiyang Kang, et al.Medicine|February 13, 2015
Prognostic significance of programmed cell death 1 (PD-1) or PD-1 ligand 1 (PD-L1) Expression in epithelial-originated cancer: a meta-analysisYaxiong Zhang, Shiyang Kang, Jianfei Shen, et al.Briefings in Bioinformatics|December 17, 2022
dSCOPE: a software to detect sequences critical for liquid-liquid phase separationKai Yu, Zekun Liu, Haoyang Cheng, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 7, 2015
Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR MutationNan Chen, Wenfeng Fang, Jianhua Zhan, et al.Journal of the National Cancer Institute|November 1, 2016
Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting: A Network Meta-AnalysisYaxiong Zhang, Yunpeng Yang, Zhonghan Zhang, et al.Plos One|June 3, 2015
The efficacy of combining antiangiogenic agents with chemotherapy for patients with advanced non-small cell lung cancer who failed first-line chemotherapy: a systematic review and meta-analysisJin Sheng, Yunpeng Yang, Yuxiang Ma, et al.Journal of Thoracic Disease|April 30, 2015
Evaluation of the efficacy and safety of anti-PD-1 and anti-PD-L1 antibody in the treatment of non-small cell lung cancer (NSCLC): a meta-analysisMinghan Jia, Weijiao Feng, Shiyang Kang, et al.Oncotarget|April 21, 2015
The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIsYanna Tang, Wenfeng Fang, Yaxiong Zhang, et al.Future Oncology (London, England)|July 19, 2018
Optimal prophylaxis of chemotherapy-induced nausea and vomiting for moderately emetogenic chemotherapy: a meta-analysisYaxiong Zhang, Xue Hou, Rong Zhang, et al.Chinese Journal of Cancer|November 27, 2016
Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatmentWenhua Liang, Guanzhu Shen, Yaxiong Zhang, et al.Pageof 3